Velocity Property Group’s (Velocity) corporate advisor BlueMount Capital (QLD) Pty Ltd (BlueMount) has assisted with the origination and investment structuring of the recent transaction by 360 Capital entities.

The transaction comprises multiple components, strategies and capital funding sources to reposition Velocity to become a high growth developer of predominantly owner occupier product in south-east Queensland. The transaction value exceeds $10m.

BlueMount’s Managing Director, Dr Mark Rainbird, states “I am delighted to announce that we have assisted with the structuring of the transaction to support Velocity and it’s growth via this cornerstone investment”.

BlueMount Capital worked closely to devise an investment banking initiative to re-capitlize for future growth while engaging discussions with global and local strategic institutional partners.

About Velocity Property Group

Velocity Property Group was established by Managing Director Brendon Ansell and listed on the Australian Stock Exchange (ASX: VP7) in 2017. Velocity Property Group creates luxury, multi-unit developments in south-east Queensland that are specifically designed for the owner-occupier, empty-nester market and mixed use / commercial developments that enhance local communities.

About BlueMount Capital

BlueMount Capital is an Australia based investment firm and corporate finance group assisting and advising corporate clients on listing on the ASX, M&A, private placements, cross border transactions and the raising of capital from the equity and debt markets. For more information please email brisbane@bluemountcapital.com or phone +61 7 3160 2840.

Dr Mark Rainbird
Managing Director,
BlueMount Capital

Melbourne (18 December 2019) —Cross Border M&A activity is increasing rapidly with 2020 expected to be a breakout year in Australia/Asia. However, the field remains littered with transactions where significant value was lost and the transactions did not perform because a major hurdle of the Cultural Differences were inadequately addressed.

BlueMount Capital Victoria and BlueMount Capital (Beijing) Co., Ltd have partnered with Global PMI Partners, an international firm widely recognised as one of the world leaders in M&A and who specialise in post-merger integration (PMI).

BlueMount Capital Beijing’s Executive President, Dr Mona Chung, is internationally recognised for her unique and ground-breaking work in dealing with the Cultural Differences between Western and Eastern Cultures, particularly, between China and the West.

BlueMount Capital and Global PMI Partners held a joint webinar on 11th of December, 2019, titled “Overcoming Cultural Differences in Cross Border M&A“. It was a very successful presentation and multiple high levels of positive feedback has been received.

A video recording of the webinar is available for viewing below.

Click here to download the slides.

About BlueMount Capital

BlueMount Capital Group is an ASIC licensed, mid-tier, global investment banking and corporate advisory group headquartered in Australia. BlueMount’s team members are highly skilled professionals with global experience and a proven track record in equity and debt financings, M&A, Divestments, MBOs and MBIs, IPOs and RTOs and Cross Border transactions. BlueMount Capital’s key areas of differentiation are its international market connectivity and the ability to deliver a broad range of investment banking and corporate advisory services effectively and efficiently.

Its on-the-ground representation in China, Singapore, Hong Kong, North America, United Kingdom, Europe, New Zealand and Africa gives clients the reach of major corporate finance houses with the service, feel and costs of a mid-tier group.

For more information please contact:

Dr Mona Chung
Executive President
BlueMount Capital, Beijing
mona.chung@bluemountcapital.com
+61 3 8622 8622, +61 414 271 678 or +86 159 2110 6974

BlueMount Capital is pleased to advise that we have been appointed as an exclusive Corporate Advisor to the Medcan Group Pty Ltd.

Founded in Australia in 2016, Medcan is a medicinal cannabis cultivation, production, research and manufacturing company aiming to apply state of the art technologies to produce medicinal cannabis and associated medicinal cannabis products. The Company holds the full suite of licences issued by the Australian Office of Drug Control (ODC) and holds the relevant State and Biosecurity licences to allow the execution of Medcan’s business plan. The Company is planning to expand its current import and distribution business and the commissioning of its manufacturing facility.

Key Highlights:

• Medcan plans to become a complete ‘seed to sale’ facility;
• The Company has existing import and distribution operations;
• Medcan is amongst a handful of Australia companies holding the entire suite of Australian Office of Drug Control (ODC) licences:
  • Cannabis Research Licence;
  • Medicinal Cannabis Cultivation and Production Licence;
  • Manufacture Licence;
  • Import & Export Licences;
• Medcan also holds the following State and Biosecurity licences:
  • Queensland Poisons Licence;
  • Queensland Wholesaling Licence;
  • DAWR Permit
• The planned Medcan facility fit out has both DA & BA (Local Council) approval;
• Medcan’s Cannabis Research and Development centre has been constructed and inspected by the Australian Office of Drug Control (ODC – awaiting final permit approval);
• The Company holds signed offtake agreements for over 65% of production for an approx. value of up to $25m with further offtake agreements in the pipeline;
• Medcan has also signed manufacturing agreements with other cultivators who intend to use Medcan to process and manufacture their end products.

Market:

• The Australian Medicinal Cannabis market is forecast to grow from $52m in 2018 to $1.2B in 2027.
• The global legal marijuana market is expected to reach US$66.3B by the end of 2025 and is anticipated to grow at 23.9% over the period.

BlueMount Capital will strategically assist Medcan with corporate and capital raising advice. For more information please click here or contact us.

Dr Mark Rainbird
Managing Director
BlueMount Capital

I am delighted to announce that we have secured AUD $3.5 million in expansion debt financing for Elite Military Fitness (EMF), a leading Gold Coast based fitness and performance group.

EMF has built a chain of fitness and performance centres focused on providing the affordability of a small 24-hour gym, the personal service of a health club and the amenities and equipment of an elite training facility. EMF’s fitness centres were created to bring a more professional and personalised service to the community without the added expense. The Company’s aim is to offer a complete fitness model to the general population; a facility that caters for everyone’s needs without overcrowding and limited equipment.

The funds will be used to expand the group’s footprint, incorporating new centres, as well as providing equipment finance. The funding includes a range of business facilities such as loans, equipment finance, credit cards and a bank guarantee.

BlueMount Capital worked closely with the new funder and the client to secure the facilities, managing the approach to the market, providing financial modelling to support the transaction and negotiating with the financier, plus assisting with closing the transaction. The facilities provided, include flexible covenants for future growth while providing competitive interest rates on all the products offered. The funding is expected to assist in meeting the groups rapid expansion plans.

EMF co-founder Scott Freeman states “BlueMount Capital has been paramount in EMF realising our dream to delivering affordable and innovative health and fitness solutions to the greater Australian community. Their assistance has helped us create our new Nerang Performance and Recovery Centre and will be assisting us with our venture in our North Lakes venue later in 2019. The future for EMF is only looking brighter.”

About BlueMount Capital

BlueMount Capital is an Australia based investment firm and corporate finance group assisting and advising corporate clients on listing on the ASX, M&A, private placements, cross border transactions and the raising of capital from the equity and debt markets. For more information please email brisbane@bluemountcapital.com or phone +61 7 3160 2840.

• Bangladesh Infrastructure Finance Fund Limited and BlueMount Capital execute Memorandum of Understanding (MOU) to cooperate
• The MOU sets out the basis for collaboration to secure international finance and investments for selected infrastructure and green technology projects
• The Parties will target several major projects for international financing

Bangladesh Infrastructure Finance Fund Limited (BIFFL), one of the major government-owned non-bank financial institutions focused largely on infrastructure projects and BlueMount Capital, an Australian-headquartered corporate finance house signed an MOU to collaborate on international financing of infrastructure and green projects in Bangladesh.

Bangladesh’s GDP has grown at a rate of 7% per annum for the past 10 years and the country has enormous infrastructure financing requirement to meet its goal of becoming a middle-income country by 2021 and achieving Sustainable Development Goals (SDG) by 2030.

BIFFL has already financed 40 projects in Bangladesh and have a robust project pipeline at different stages of development.

Traditionally, Bangladesh has utilised soft-loan funds from the Asian Development Bank, World Bank and similar international finance institutions.

Under the MOU, BlueMount Capital will work with BIFFL on corporate and commercial investment and financing channels.

The Parties will cooperate to secure support from the Bangladesh Government for guarantees and appropriate incentives, in applicable cases, to attract international investment.

“We are pleased with this initiative to broaden our inbound investment channels with an international corporate finance house such as BlueMount Capital,” said the Executive Director and CEO of BIFFL Mr S.M. Formanul Islam.

“Bangladesh has several attractive infrastructure and energy projects ranging in scale and stages of development,

“We have more than US$ 2 billion of investment and financing opportunities for infrastructure and energy projects” said Mr Islam.

BlueMount Capital Chairman Dr Saliba Sassine said the group is looking forward to working closely with BIFFL and to promoting investment opportunities to international investment houses focused on emerging markets or energy and infrastructure opportunities.

“Bangladesh location makes it a strategic bridge between South Asia and South East Asia,” said Dr Sassine.

“Combined this with strong growth over the past decade, a liberal and multi-party system of government and a good mix of skills and education among its workforce, Bangladesh is well poised to become a strong Tiger Economy.”

BIFFL and BlueMount aim to action their efforts in early 2019 with a selection of opportunities.

BlueMount Capital is pleased to advise that we have been appointed Corporate Advisor by Qponics Limited.

Qponics Limited is a Brisbane based company focused on the sustainable production of EPA Omega-3 oils and other high-value products from Australian strains of algae.

The Company is planning to upgrade the existing pilot algae farm, to purchase a property for its commercial algae farm and submitting the DA and preparing to list on a suitable Australian stock exchange via an IPO in 2019.

The upgraded pilot algae farm in Brisbane and Qponics’ largescale algae farm to be built on the proposed 167.5 ha site at South Ballina will sustainably produce algae, from which omega-3 oil and high-protein biomass as a by-product will be extracted, integrating state-of-the-art technologies to maximise automation and minimise operational costs.

Our assignment will comprise being the corporate advisor, and raising funds now for a pre-IPO raising of $7M immediately followed by an IPO in 2019. For more information please click here or contact us.

Dr Mark Rainbird
Managing Director
BlueMount Capital

BlueMount Capital has been appointed as Corporate Advisor to PROJECT ENERGISE. The client carbonTRACK has developed advanced and innovative software and hardware which allows users to monitor, manage and optimize their energy usage, maximising savings and even allowing users to trade and arbitrage energy.

With its head office located in Melbourne, carbonTRACK commenced operations in 2015. Since then this award winning technology has been deployed in Australia New Zealand and Africa. Funds are now being raised to expand current operations and to support entry and growth in the U.S.A.

BlueMount Capital will lead the raising of $10m. An Investment Deck and Information Memorandum are now available and further details can be accessed on this website.

BlueMount Capital Sydney has partnered with a leading private non-bank lender with a capital pool of $1.3B for commercial property developers that specialises in loans from $1M to $200M.

In 2017 the lender settled $1.8B in loans and looks set to exceed $2B in the financial year to June 2018. Developments can be both residential or commercial in any state with a preference for capital cities or larger regional centres.

Loans are available for property developers for the following types of projects;

• Bridging finance
• Construction finance
• Commercial Property purchases and refinance
• Residential Property where the funds are used for commercial purposes
• Land Banking for developers
• Development Sites

Rates start from 6.5% plus line & establishment fees. 

Initial Documentation Required 

• Overview of the project with key metrics summarised
• Valuation if available. An old report will suffice. If a valuation is not available, please provide the address and estimated value.
• Copy of the contract of sale (if acquisition).
• Details (lender and outstanding balance) of any mortgages currently on the property.
• Feasibility study for the project – for a construction loan only
• Level of presales achieved to date. – for a construction loan only

For more information or to make an application contact Ross McDowall in the Sydney office.